Mount Nittany Medical Center
State College, Pennsylvania, 16801, United States
NCT Number: NCT01394328
The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized that factors such as CNS-active medications, urinary tract infection, stage of dementia, pain, activity level, and dehydration would be associated with an increased risk of delirium and delirium severity in patients with dementia compared to dementia patients without delirium. It was also hypothesized that persons with DSD will have worse outcomes (longer hospital length of stays, decreased functional status, a steeper negative slope of cognitive decline) than dementia patients without delirium. Lastly, it was hypothesized that higher delirium severity would be associated with poorer outcomes in persons with dementia. The long-term objectives were to use the results from this study to design and test an intervention strategy to improve early recognition, management, prevention, and outcomes in persons with DSD.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
State College, Pennsylvania, 16801, United States
It is well known that persons with dementia are at increased risk of developing delirium or acute confusional state. Further, current evidence suggests that delirium may worsen the prognosis of dementia, may alter the clinical course and trajectory of cognitive decline, and may be associated with substantially worse long-term outcomes. This study was a prospective cohort study design involving 165 hospitalized subjects with dementia who were 65 and older and included a three month follow up period. Aims for the study included: 1) to identify risk factors for DSD, and 2) to describe post-hospital outcomes and the trajectory of cognitive decline for DSD, which will justify the development of appropriate preventative and management strategies for delirium in patients with dementia. Delirium was assessed daily from admission to discharge and then at one and three month follow-ups. The potential risk factors being examined were 1) polypharmacy (central nervous system-active medications, number of medications, new medications added), 2) physical stressors (urinary tract infection, pain, dehydration), and 3) environmental stressors (bedrest, restraints, room changes). Outcomes were assessed by research study staff blinded to the study aims.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Participants will be assessed 1 month after date of hospital discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Participants will be assessed 3 months after date of hospital discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Time frame: Duration of hospitalization, expected to be about 5 days
Time frame: Daily until discharge, expected to be about 5 days
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Participant will be assessed 1 month after date of hospital discharge
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Participant will be assessed 3 months after date of hospital discharge
Measured using the KATZ ADL Scale and Lawton Index of Daily Living
Time frame: Daily until discharge, expected to be about 5 days
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Time frame: Participant will be assessed 1 month after date of hospital discharge
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Time frame: Participant will be assessed 3 months after date of hospital discharge
MMSE and Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) used to measure cognition
Penn State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01505257
Brain Diseases, Central Nervous System Diseases
State College, Pennsylvania, United States
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT05398211
Confusion, Delirium
Oslo, Norway
View Trial DetailsNCT05915377
Confusion, Delirium
Boston, Massachusetts, United States
View Trial Details